| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.2 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.2 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.2 |